Read the full stored bill text
Illinois General Assembly - Full Text of HB4203
Select Language
×
The Illinois General Assembly offers the Google Translate™ service for visitor convenience. In no way should it be considered accurate as to the translation of any content herein.
Visitors of the Illinois General Assembly website are encouraged to use other translation services available on the internet.
The English language version is always the official and authoritative version of this website.
NOTE: To return to the original English language version, select the "Show Original" button on the Google Translate™ menu bar at the top of the window.
Choose Language
English
Afrikaans
Albanian
Arabic
Armenian
Azerbaijani
Basque
Bengali
Bosnian
Catalan
Croatian
Czech
Danish
Dutch
Esperanto
Estonian
Filipino
Finnish
French
Galician
Georgian
German
Greek
Gujarati
Haitian Creole
Hausa
Hawaiian
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Interlingua
Interlingue
Inuktitut
Irish
Italian
Japanese
Javanese
Kannada
Khmer
Korean
Latin
Latvian
Lithuanian
Luxembourgish
Macedonian
Malagasy
Malayalam
Maltese
Maori
Marathi
Myanmar
Nepali
Norwegian
Odia
Pashto
Punjabi
Romanian
Russian
Samoan
Sango
Sanskrit
Sardinian
Sindhi
Sinhala
Slovak
Slovenian
Somali
Southern Sotho
Spanish
Sundanese
Swahili
Swedish
Tamil
Telugu
Thai
Tigrinya
Tonga
Turkish
Ukrainian
Urdu
Vietnamese
Welsh
Xhosa
Yiddish
Yoruba
Zulu
Powered by
Translate
Close
Illinois General Assembly
Top Navigation Bar
Translate
Learn
Select General Assembly
Search the 104th General Assembly
Enter search terms for legislation, members, committees, or schedules.
ILGA.GOV
LEGISLATION & LAWS
Bills & Resolutions
Public Acts
Illinois Compiled Statutes
Illinois Constitution
Search Legislation
Glossary
Guide
Reports & Inquiry
Legislative Reports
Special Reports
FTP Site
Legislator Lookup
Capitol Complex Phone Numbers
Rules & Regulations
Illinois Register
Administrative Rules
Senate
Members
Schedules
Committees
Request for Remote Testimony
Journals
Transcripts
Rules
Audio/Video
FOIA Information
Senate Employment Opportunities
Media Guidelines
House
Members
Schedules
Committees
Submit testimony for House Committees
Journals
Transcripts
Rules
Audio/Video
FOIA Information
House Employment Opportunities
Log In
Mobile Top Bar
Search the 104th General Assembly
Enter keywords to search the Illinois General Assembly website.
Full Text of HB4203
Home
Legislation
Full Text
HB4203 - 104th General Assembly
Bill Status
Full Text
Votes
Witness Slips
Select Menu
Bill Status
Full Text
Votes
Witness Slips
Printer Friendly Version
Introduced
Engrossed
Enrolled
Senate Amendment 001
Public Act
Printer Friendly Version
Introduced
Engrossed
Enrolled
Senate Amendment 001
Public Act
Open PDF
HB4203 Enrolled
LRB104 15932 BAB 29167 b
1
AN ACT concerning regulation.
2
Be it enacted by the People of the State of Illinois,
3
represented in the General Assembly:
4
Section 5.
The Illinois Insurance Code is amended by
5
changing Section 356u as follows:
6
(215 ILCS 5/356u)
7
Sec. 356u.
Pap tests and prostate cancer screenings.
8
(a) A group policy of accident and health insurance that
9
provides coverage for hospital or medical treatment or
10
services for illness on an expense-incurred basis and is
11
amended, delivered, issued, or renewed
on or
after January 1,
12
2028
2024
shall provide coverage, without imposing a
13
deductible, coinsurance, copayment, or any other cost-sharing
14
requirement, for all of the following:
15
(1) An annual cervical smear or Pap smear test for all
16
insureds.
17
(2) An annual prostate cancer screening for insureds
18
upon the recommendation of a physician licensed to
19
practice medicine in all its branches for:
20
(A) asymptomatic individuals age 50 and over;
21
(B) African-American individuals age 40 and over;
22
and
23
(C) individuals age 40 and over with a family
HB4203 Enrolled
- 2 -
LRB104 15932 BAB 29167 b
1
history of or genetic predisposition to prostate
2
cancer.
3
(3)
An annual screening
Surveillance tests
for ovarian
4
cancer for insureds who are at risk for ovarian cancer
5
using (i) CA-125 serum tumor marker testing, (ii)
6
transvaginal ultrasound, and (iii) pelvic examination
.
7
(a-5) A group policy of accident and health insurance that
8
provides coverage for hospital or medical treatment or
9
services for illness on an expense-incurred basis and is
10
amended, delivered, issued, or renewed on or after January 1,
11
2028 shall, in addition to the coverage required under
12
paragraph (3) of subsection (a), provide coverage for all
13
medically viable methods for the detection and diagnosis of
14
ovarian cancer for insureds who are at risk for ovarian
15
cancer, including, but not limited to, ultrasounds, magnetic
16
resonance imagings (MRIs), x-rays, computed tomography (CT)
17
scans, and CA-125 blood test screenings. The coverage required
18
under this subsection may be subject to a deductible,
19
coinsurance, or other cost sharing.
20
(b) This Section shall not apply to agreements, contracts,
21
or policies that provide coverage for a specified disease or
22
other limited benefit coverage.
23
(c) This Section does not apply to coverage of prostate
24
cancer screenings to the extent such coverage would disqualify
25
a high-deductible health plan from eligibility for a health
26
savings account pursuant to Section 223 of the Internal
HB4203 Enrolled
- 3 -
LRB104 15932 BAB 29167 b
1
Revenue Code.
2
(d) For the purposes of this Section:
3
"At risk for ovarian cancer" means:
4
(1) having a family history (i) with one or more
5
first-degree relatives with ovarian cancer, (ii) of
6
clusters of relatives with breast cancer, or (iii) of
7
nonpolyposis colorectal cancer;
or
8
(2) testing positive for BRCA1 or BRCA2 mutations
; or
.
9
(3) having a high level of CA-125, as indicated by a
10
blood test screening.
11
"Prostate cancer screening" means medically viable methods
12
for the detection and diagnosis of prostate cancer, including
13
a digital rectal exam and the prostate-specific antigen test
14
and associated laboratory work. "Prostate cancer screening"
15
includes medically necessary subsequent follow-up testing as
16
directed by a health care provider, including, but not limited
17
to:
18
(1) urinary analysis;
19
(2) serum biomarkers; and
20
(3) medical imaging, including, but not limited to,
21
magnetic resonance imaging.
22
"Surveillance tests for ovarian cancer" means annual
23
screening using (i) CA-125 serum tumor marker testing, (ii)
24
transvaginal ultrasound, (iii) pelvic examination.
25
(Source: P.A. 102-1073, eff. 1-1-23; 103-30, eff. 1-1-25
.)
26
Section 99.
Effective date.
This Act takes effect January
HB4203 Enrolled
- 4 -
LRB104 15932 BAB 29167 b
1
1, 2028.
Footer
Disclaimer
This site is maintained for the Illinois General Assembly by the
Legislative Information System, 705 Stratton Building, Springfield, Illinois 62706.
Contact ILGA Webmaster
ILGA.gov uses cookies to ensure you get the best experience on our website. By continuing to browse ILGA.gov you consent to our use of cookies.
Read About Cookies
ILGA.GOV
2026 ILGA.gov | All Rights Reserved |
ADA
|
Disclaimers
|
Learn
This site is maintained for the Illinois General Assembly by the
Legislative Information System, 705 Stratton Building, Springfield, Illinois 62706.
Contact ILGA Webmaster
ILGA.gov uses cookies to ensure you get the best experience on our website. By continuing to browse ILGA.gov you consent to our use of cookies.
Read About Cookies
ILGA.GOV
2026 ILGA.gov | All Rights Reserved |
ADA
|
Disclaimers
|
Learn